• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    7/24/23 3:48:22 PM ET
    $ADCT
    $ADTX
    $AIRG
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADCT alert in real time by email

     

    On Monday morning, 70 companies achieved new lows for the year.

    Interesting Facts About Today's 52-Week Lows:

    • Estee Lauder Cos (NYSE:EL) was the largest firm by market cap to set a new 52-week low.
    • 9 Meters Biopharma (NASDAQ:NMTR) was the smallest firm on a market cap basis to set a new 52-week low.
    • AppHarvest (NASDAQ:APPH) was the biggest loser, trading down 70.3% to reach its 52-week low.
    • SWK Holdings (NASDAQ:SWKH) was the biggest winner of the bunch, with shares actually trading up 0.0% after it rebounded from its new 52-week low.

    Over the course of the first half-hour of trading on Monday, the following stocks hit new 52-week lows:

    • Estee Lauder Cos (NYSE:EL) stock broke to a new 52-week low of $171.94 on Monday. Shares of the company traded down 2.62%.
    • NovoCure (NASDAQ:NVCR) stock broke to a new 52-week low of $37.92 on Monday. Shares of the company traded down 2.0%.
    • Apellis Pharmaceuticals (NASDAQ:APLS) stock drifted down 2.66% on Monday morning to hit a new 52-week low of $32.75.
    • Cytokinetics (NASDAQ:CYTK) shares were down 0.95% for the day, having made a 52-week low of $32.05.
    • Nu Skin Enterprises (NYSE:NUS) shares moved down 0.12% on Monday to hit a new 52-week low of $28.18, drifting down 0.12%.
    • Lifezone Metals (NYSE:LZM) stock achieved a new 52-week low on Monday morning, hitting $9.03 and moving down 11.94%.
    • Avidity Biosciences (NASDAQ:RNA) stock drifted down 2.74% on Monday morning to hit a new 52-week low of $9.71.
    • Beneficient (NASDAQ:BENF) stock drifted down 3.24% on Monday morning to hit a new 52-week low of $2.03.
    • uniQure (NASDAQ:QURE) stock achieved a new 52-week low on Monday morning, hitting $9.72 and moving down 1.75%.
    • AnaptysBio (NASDAQ:ANAB) shares hit a yearly low of $17.51. The stock was down 2.57% on the session.
    • Enanta Pharma (NASDAQ:ENTA) shares moved down 2.87% on Monday to hit a new 52-week low of $18.17, drifting down 2.87%.
    • Compute Health (NYSE:CPUH) stock hit $9.70 on Monday morning, setting a new 52-week low for a change of down 0.28%.
    • BRC (NYSE:BRCC) shares made a new 52-week low of $4.76 on Monday. The stock was down 2.44% for the day.
    • SWK Holdings (NASDAQ:SWKH) stock hit a new 52-week low of $16.10. The stock was 0.0% (flat) on the session.
    • FibroGen (NASDAQ:FGEN) shares fell to $1.98 on Monday, setting a new 52-week low with a shift of down 3.88%.
    • Inogen (NASDAQ:INGN) shares set a new 52-week low of $8.32. The stock traded down 2.43%.
    • Kodiak Sciences (NASDAQ:KOD) shares made a new 52-week low of $2.77 on Monday. The stock was down 50.48% for the day.
    • Altimmune (NASDAQ:ALT) stock hit a yearly low of $3.04. The stock was down 1.95% for the day.
    • ADC Therapeutics (NYSE:ADCT) shares were down 3.87% for the day, having made a 52-week low of $1.35.
    • Carmell Therapeutics (NASDAQ:CTCX) stock dropped to a yearly low on Monday of $4.60. Shares traded down 11.03%.
    • CEL-SCI (AMEX:CVM) stock achieved a new 52-week low on Monday morning, hitting $1.78 and moving down 8.88%.
    • Durect (NASDAQ:DRRX) stock dropped to a yearly low on Monday of $2.96. Shares traded up 0.98%.
    • Theratechnologies (NASDAQ:THTX) shares made a new 52-week low of $0.58 on Monday. The stock was down 11.97% for the day.
    • Airgain (NASDAQ:AIRG) shares set a new 52-week low of $4.76. The stock traded up 0.41%.
    • Westwater Resources (AMEX:WWR) stock dropped to a yearly low on Monday of $0.77. Shares traded up 2.81%.
    • Nautilus (NYSE:NLS) shares moved up 1.42% on Monday to hit a new 52-week low of $1.04, drifting up 1.42%.
    • Interactive Strength (NASDAQ:TRNR) shares moved down 7.57% on Monday to hit a new 52-week low of $2.00, drifting down 7.57%.
    • Purple Biotech (NASDAQ:PPBT) stock achieved a new 52-week low on Monday morning, hitting $1.18 and moving down 1.64%.
    • BioCardia (NASDAQ:BCDA) stock hit a new 52-week low of $1.01. The stock was down 46.97% on the session.
    • Zivo Bioscience (NASDAQ:ZIVO) shares moved up 1.61% on Monday to hit a new 52-week low of $1.76, drifting up 1.61%.
    • WANG & LEE Group (NASDAQ:WLGS) stock hit $1.11 on Monday morning, setting a new 52-week low for a change of down 1.74%.
    • Addentax Group (NASDAQ:ATXG) stock hit a new 52-week low of $3.83. The stock was down 5.69% on the session.
    • AERWINS Technologies (NASDAQ:AWIN) stock hit a new 52-week low of $0.25. The stock was down 6.54% on the session.
    • Cadrenal Therapeutics (NASDAQ:CVKD) stock dropped to a yearly low on Monday of $1.04. Shares traded down 12.34%.
    • Greenbrook TMS (NASDAQ:GBNH) stock broke to a new 52-week low of $0.31 on Monday. Shares of the company traded down 9.81%.
    • 60 Degrees (NASDAQ:SXTP) shares reached a new 52-week low of $2.31 on Monday morning, moving down 11.61%.
    • Golden Minerals (AMEX:AUMN) stock achieved a new 52-week low on Monday morning, hitting $1.33 and moving down 2.84%.
    • GRI Bio (NASDAQ:GRI) shares set a new yearly low of $3.53 this morning. The stock was down 0.84% on the session.
    • Powerbridge Technologies (NASDAQ:PBTS) stock drifted down 4.75% on Monday morning to hit a new 52-week low of $0.30.
    • Bio-Path Hldgs (NASDAQ:BPTH) shares hit a yearly low of $1.17. The stock was down 2.5% on the session.
    • Taoping (NASDAQ:TAOP) shares set a new 52-week low of $0.47. The stock traded down 2.02%.
    • Siyata Mobile (NASDAQ:SYTA) shares reached a new 52-week low of $0.04 on Monday morning, moving down 5.47%.
    • Titan Pharma (NASDAQ:TTNP) stock dropped to a yearly low on Monday of $0.51. Shares traded down 1.12%.
    • Micromobility com (NASDAQ:MCOM) shares fell to $0.08 on Monday, setting a new 52-week low with a shift of down 4.92%.
    • ViewRay (NASDAQ:VRAY) shares set a new 52-week low of $0.04. The stock traded down 31.69%.
    • FOXO Technologies (AMEX:FOXO) shares set a new 52-week low of $0.13. The stock traded down 3.13%.
    • Lixte Biotech Hldgs (NASDAQ:LIXT) shares set a new yearly low of $4.03 this morning. The stock was down 4.05% on the session.
    • iSun (NASDAQ:ISUN) stock dropped to a yearly low on Monday of $0.33. Shares traded down 6.59%.
    • Shineco (NASDAQ:SISI) shares reached a new 52-week low of $0.22 on Monday morning, moving down 7.5%.
    • C3is (NASDAQ:CISS) shares fell to $0.70 on Monday, setting a new 52-week low with a shift of down 4.48%.
    • SuperCom (NASDAQ:SPCB) stock drifted down 3.72% on Monday morning to hit a new 52-week low of $0.78.
    • Ra Medical Systems (AMEX:RMED) shares hit a yearly low of $0.61. The stock was up 1.03% on the session.
    • ZyVersa Therapeutics (NASDAQ:ZVSA) shares reached a new 52-week low of $0.16 on Monday morning, moving down 12.55%.
    • Salarius Pharmaceuticals (NASDAQ:SLRX) stock hit a new 52-week low of $1.00. The stock was down 1.43% on the session.
    • Avalo Therapeutics (NASDAQ:AVTX) shares were down 13.87% for the day, having made a 52-week low of $0.25.
    • Grom Social Enterprises (NASDAQ:GROM) shares hit a yearly low of $0.29. The stock was down 11.11% on the session.
    • Aditxt (NASDAQ:ADTX) shares were down 1.84% for the day, having made a 52-week low of $0.40.
    • E-Home Household Service (NASDAQ:EJH) stock hit a new 52-week low of $0.10. The stock was down 11.83% on the session.
    • Esports Entertainment (NASDAQ:GMBL) shares reached a new 52-week low of $0.56 on Monday morning, moving down 2.38%.
    • BitNile Metaverse (NASDAQ:BNMV) shares hit a yearly low of $0.93. The stock was down 8.1% on the session.
    • Sigma Additive Solutions (NASDAQ:SASI) stock hit a yearly low of $0.19. The stock was down 12.17% for the day.
    • 9 Meters Biopharma (NASDAQ:NMTR) stock dropped to a yearly low on Monday of $0.12. Shares traded down 13.01%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ADCT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADCT
    $ADTX
    $AIRG
    $ALT

    CompanyDatePrice TargetRatingAnalyst
    Altimmune Inc.
    $ALT
    4/24/2026$2.50Sell → Neutral
    Goldman
    Cytokinetics Incorporated
    $CYTK
    4/10/2026$95.00Overweight
    Wells Fargo
    Avalo Therapeutics Inc.
    $AVTX
    4/9/2026$48.00Outperform
    Wolfe Research
    Avalo Therapeutics Inc.
    $AVTX
    4/6/2026$52.00Mkt Outperform
    Citizens
    Enanta Pharmaceuticals Inc.
    $ENTA
    3/26/2026$20.00Buy
    Rodman & Renshaw
    Altimmune Inc.
    $ALT
    3/18/2026$12.00Buy
    Truist
    Apellis Pharmaceuticals Inc.
    $APLS
    3/13/2026$31.00Buy
    Roth Capital
    Atrium Therapeutics Inc.
    $RNA
    3/11/2026$25.00Overweight
    Wells Fargo
    More analyst ratings

    $ADCT
    $ADTX
    $AIRG
    $ALT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-5) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:04:01 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-4) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:03:14 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $ADTX
    $AIRG
    $ALT
    SEC Filings

    View All

    SEC Form 424B5 filed by Altimmune Inc.

    424B5 - Altimmune, Inc. (0001326190) (Filer)

    4/23/26 9:29:55 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by Aditxt Inc.

    424B3 - Aditxt, Inc. (0001726711) (Filer)

    4/23/26 4:30:42 PM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by C3is Inc.

    6-K - C3is Inc. (0001951067) (Filer)

    4/23/26 4:15:10 PM ET
    $CISS
    Marine Transportation
    Consumer Discretionary

    $ADCT
    $ADTX
    $AIRG
    $ALT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Altimmune upgraded by Goldman with a new price target

    Goldman upgraded Altimmune from Sell to Neutral and set a new price target of $2.50

    4/24/26 7:59:47 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Wells Fargo initiated coverage on Cytokinetics with a new price target

    Wells Fargo initiated coverage of Cytokinetics with a rating of Overweight and set a new price target of $95.00

    4/10/26 8:40:13 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Wolfe Research initiated coverage on Avalo Therapeutics with a new price target

    Wolfe Research initiated coverage of Avalo Therapeutics with a rating of Outperform and set a new price target of $48.00

    4/9/26 8:40:45 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $ADTX
    $AIRG
    $ALT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $24,061 worth of Class A Shares (72,912 units at $0.33) and sold $3,595 worth of Class A Shares (11,982 units at $0.30), increasing direct ownership by 100% to 121,592 units (SEC Form 4)

    4 - Aditxt, Inc. (0001726711) (Issuer)

    4/23/26 3:43:04 PM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Hrt Financial Lp claimed ownership of 133,574 units of Class A Shares (SEC Form 3)

    3 - Aditxt, Inc. (0001726711) (Issuer)

    4/23/26 3:37:12 PM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Kenney Stephanie

    4 - Atrium Therapeutics, Inc. (0002093101) (Issuer)

    4/22/26 5:54:12 PM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $ADTX
    $AIRG
    $ALT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $24,061 worth of Class A Shares (72,912 units at $0.33) and sold $3,595 worth of Class A Shares (11,982 units at $0.30), increasing direct ownership by 100% to 121,592 units (SEC Form 4)

    4 - Aditxt, Inc. (0001726711) (Issuer)

    4/23/26 3:43:04 PM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Taslitz Steven bought $223,500 worth of shares (300,000 units at $0.74), increasing direct ownership by 33% to 601,184 units (SEC Form 4)

    4 - BRC Inc. (0001891101) (Issuer)

    3/9/26 5:08:04 PM ET
    $BRCC
    Beverages (Production/Distribution)
    Consumer Staples

    Chief Financial Officer Weaver Gregory L bought $17,700 worth of shares (5,000 units at $3.54), increasing direct ownership by 22% to 28,078 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    3/9/26 7:05:04 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $ADTX
    $AIRG
    $ALT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lifezone Metals Announces Closing of $25 Million Registered Direct Offering

    Lifezone Metals Limited (NYSE:LZM) announced today the closing of its previously announced1 share purchase agreement with institutional investors for the sale of 5,700,000 ordinary shares at a price of $4.40 per share. The offering raised approximately $25 million in gross proceeds to the Company, before deducting placement agent fees and offering-related expenses. The net proceeds of this offering will be used for exploration activities in Burundi and Tanzania, the PGM Recycling Project, conducting Hydromet research and development at Simulus Laboratory, and for other general corporate and working capital purposes, including financing costs. Current pre-FID, early-stage work, and project

    4/23/26 4:30:00 PM ET
    $LZM
    Metal Mining
    Basic Materials

    SuperCom to Report Fourth Quarter and Full Year 2025 Financial Results on April 28th, 2026

    TEL AVIV, Israel, April 23, 2026 /PRNewswire/ -- SuperCom (NASDAQ:SPCB), a global provider of secured solutions for the e-Government, IoT and Cybersecurity sectors, will hold a conference call on Tuesday, April 28, 2026, at 10 a.m. Eastern time (7 a.m. Pacific Time / 5 p.m. IL time) to discuss its financial results for the fourth quarter and year ended December 31, 2025. Financial results will be issued in a press release prior to the call. SuperCom management will host the conference call, followed by a question-and-answer period.Conference Call Dial-In Information:Date: Tuesday, April 28, 2026Time: 10 a.m. Eastern time (7 a.m. Pacific time)U.S. toll-free: 888-506-0062Israel toll-free: 1-80

    4/23/26 9:28:00 AM ET
    $SPCB
    Semiconductors
    Technology

    C3is Inc. Announces Reverse Stock Split

    To be effective April 27, 2026 Aiming to meet the minimum bid price requirement for maintaining listing on Nasdaq ATHENS, Greece, April 23, 2026 (GLOBE NEWSWIRE) -- C3is Inc. (the "Company") (NASDAQ:CISS) today announced that its board of directors has determined to effect a one-for-seven (1-for-7) reverse stock split of the Company's common stock, par value $0.01 per share. The reverse stock split will take effect at 11:59 pm Eastern Time on April 26, 2026, and the Company's common stock will begin trading on a split-adjusted basis on The Nasdaq Capital Market ("Nasdaq") as of the opening of trading on April 27, 2026. The CUSIP number of Y18284300 will be assigned to the Company's com

    4/23/26 8:30:00 AM ET
    $CISS
    Marine Transportation
    Consumer Discretionary

    $ADCT
    $ADTX
    $AIRG
    $ALT
    Leadership Updates

    Live Leadership Updates

    View All

    Inogen Announces the Appointment of Vafa Jamali to Board of Directors

    Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Vafa Jamali as an independent director to the Inogen Board of Directors (the "Board"), effective on the date of the Company's 2026 Annual Meeting, or June 15th if earlier. Mr. Jamali is a long-time medical device executive who will bring added depth and expertise to the Board. During his tenure as the Chief Executive Officer of ZimVie, he led the company's Nasdaq listing following the spin-out from Zimmer Biomet and helped each of the businesses (Spine and Dental) through significant portfolio optimization actions to support

    4/6/26 4:00:00 PM ET
    $INGN
    Industrial Specialties
    Health Care

    The Estée Lauder Companies Fully Establishes Its "One ELC" Operating Model and Reaches Milestone in Its Profit Recovery and Growth Plan

    WPP Appointed First-Ever Global Media Partner, Unifying Media Execution Worldwide "One ELC" Operating Model Is Transforming How the Company Operates at Scale The Estée Lauder Companies Inc. (NYSE:EL) today announced WPP as its first-ever global media partner, marking a significant advancement of its One ELC operating model, a scalable system designed to operate faster, execute with greater discipline, and drive growth. In fully establishing One ELC, the Company also reached a significant milestone in its Profit Recovery and Growth Plan's (PRGP) Restructuring Program — a key action plan priority of Beauty Reimagined. Stéphane de La Faverie, President and Chief Executive Officer, The Es

    4/1/26 5:00:00 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth

    Jason Richardson Named Chief Financial Officer, Succeeding Michael Bourque Dominic Hulton Named Chief Marketing Officer Corey Moritz Appointed Vice President, U.S. Business to Business Sales Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the following leadership appointments designed to accelerate the company's next phase of growth. Jason Richardson Appointed Chief Financial Officer Jason Richardson has been appointed Chief Financial Officer, effective April 6, 2026. Mr. Richardson succeeds Michael Bourque, who will step down from his role as Chief Financial Officer on that date. M

    3/30/26 4:00:00 PM ET
    $INGN
    Industrial Specialties
    Health Care

    $ADCT
    $ADTX
    $AIRG
    $ALT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/10/24 6:06:03 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/9/24 5:30:41 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/9/24 5:30:28 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    $ADCT
    $ADTX
    $AIRG
    $ALT
    Financials

    Live finance-specific insights

    View All

    SuperCom to Report Fourth Quarter and Full Year 2025 Financial Results on April 28th, 2026

    TEL AVIV, Israel, April 23, 2026 /PRNewswire/ -- SuperCom (NASDAQ:SPCB), a global provider of secured solutions for the e-Government, IoT and Cybersecurity sectors, will hold a conference call on Tuesday, April 28, 2026, at 10 a.m. Eastern time (7 a.m. Pacific Time / 5 p.m. IL time) to discuss its financial results for the fourth quarter and year ended December 31, 2025. Financial results will be issued in a press release prior to the call. SuperCom management will host the conference call, followed by a question-and-answer period.Conference Call Dial-In Information:Date: Tuesday, April 28, 2026Time: 10 a.m. Eastern time (7 a.m. Pacific time)U.S. toll-free: 888-506-0062Israel toll-free: 1-80

    4/23/26 9:28:00 AM ET
    $SPCB
    Semiconductors
    Technology

    Inogen to Report First Quarter 2026 Financial Results on May 7, 2026

    Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2026 financial results after the market closes on Thursday, May 7, 2026. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET. Individuals interested in listening to the conference call may do so by dialing: U.S. domestic callers (877) 841-3961 Non-U.S. callers (201) 689-8589 Please reference Inogen to join the call. A live audio webcast and archived recording of the conference call will be available to all interested parties through the News / Events page on the Inogen I

    4/23/26 8:30:00 AM ET
    $INGN
    Industrial Specialties
    Health Care

    Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration

    SAN DIEGO, April 23, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (NASDAQ:RNA) (the "Company"), a biopharmaceutical company dedicated to delivering RNA therapeutics directly to the heart, announced today it has earned a $15 million development milestone payment from Bristol Myers Squibb (NYSE:BMY). The milestone was achieved upon the successful delivery of a development candidate for the first licensed compound targeting a cardiology indication under the Company's ongoing collaboration. "This milestone marks a meaningful step forward for Atrium, further expanding our RNA deliv

    4/23/26 8:00:00 AM ET
    $BMY
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care